GlassScriptPhysician profile
Francisco Gonzalez
NPI 1447475611
$23,334.84
in general payments reported to CMS, 2019-2025
25 companies · $1,408 in 2025
The $1,408 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,471 · 2020: $4,855 · 2021: $1,238 · 2022: $1,812 · 2023: $1,121 · 2024: $3,430 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,104 · Travel and Lodging: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,104.27 |
| Travel and Lodging | $854.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,560.14 | 2019-2025 | Gallant, Aveir, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5,450.14 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $4,775.23 | 2019-2020 | |
| Boston Scientific Corporation | $2,505.97 | 2019-2025 | Watchman Flx, Farapulse, Rhythmia Mapping System |
| Medtronic, INC. | $2,151.77 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Linq II |
| Biosense Webster, INC. | $1,379.73 | 2019-2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $191.90 | 2019-2024 | Eliquis |
| Abbvie INC. | $184.94 | 2022-2025 | |
| Philips North America LLC | $160.76 | 2019-2025 | (5091) Amb Mon & Diag Und, Lm Undivided |
| Bardy Diagnostics, INC. | $155.02 | 2022 | |
| Zoll Respicardia, INC. | $140.71 | 2021-2025 | Remede System |
| Janssen Pharmaceuticals, INC | $130.86 | 2019-2024 | Xarelto |
| Pfizer INC. | $128.05 | 2021-2025 | |
| Inspire Medical Systems, INC. | $120.93 | 2022 | |
| Vyera Pharmaceuticals, LLC | $41.27 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $40.43 | 2025 | |
| Merck Sharp & Dohme LLC | $37.06 | 2021 | |
| Allergan, INC. | $36.14 | 2019-2020 | |
| Haemonetics Corporation | $26.78 | 2024 | Ensoetm |
| Amgen INC. | $23.51 | 2020 | |
| Medicomp INC | $23.20 | 2019 | |
| Atricure, INC. | $20.58 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $19.00 | 2024 | Farxiga |
| Idorsia Pharmaceuticals US INC | $17.00 | 2023 | Quviviq |
| Lilly USA, LLC | $13.72 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.